Arthritis Drug Orencia, Ruled Too Expensive by NICE
The arthritis drug Orencia has been approved as the treatment when all other treatments fail.
In the UK, after being ruled not cost effective The National Institute for Health and Clinical Excellence (NICE), is bad news to all the people there (who has been under treatment with Orencia) with aggressive rheumatoid arthritis.
Such a ruling went down despite appeals by The National Rheumatoid Arthritis Society (NRAS) and Bristol-Myers Squibb — maker of Orencia (abatacept). More →
I would like the patients to understand their condition better in order to help them discern what is best for their life with arthritis in conjunction to what their doctors are telling them! .. 
![PetLvr - [The Blog]](http://s3.amazonaws.com/PerfAds_Images/2_26_1214086206_banner_PetLvr_125x125.jpg)
